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Introduction
Mesenchymal stem cells (MSCs) are currently evaluated for use in
tissue engineering approaches. These stem cells are characterized
by self renewal capacity, long life-span and the potential to
differentiate into several lineages including bone, cartilage, muscle
and fat [1]. While bone marrow is a frequently used source for
MSCs, relatively low cell numbers can be isolated from bone
marrow. Recent studies have reported on the presence of
100–1000-fold higher numbers of MSCs per volume in adipose
tissue [2, 3]. Adipose tissue can be harvested from patients by
minimally invasive methods and is in general abundantly available
[4]. Therefore, adipose tissue-derived mesenchymal stem cells
(AT-MSCs) constitute a promising tool for tissue engineering
approaches targeting skeletal defects [4, 5]. One of these
approaches is a one-step surgical procedure to facilitate spinal
interbody fusion [6]. This one-step procedure consists of the
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Abstract
For bone tissue engineering, it is important that mesenchymal stem cells (MSCs) differentiate into osteoblasts. To develop a method for
differentiation of adipose tissue-derived mesenchymal stem cells (AT-MSCs) along the osteogenic lineage, we studied the effect of
polyamines, which are organic cations implicated in bone growth and development, on differentiation of AT-MSCs. Treatment of goat-
derived AT-MSCs with 1,25-dihydroxyvitamin-D3 (1,25(OH)2D3), which stimulates osteogenic differentiation, for 7 days induced gene
expression of the polyamine-modulated transcription factor-1 (PMF-1) and spermidine/spermine N (1)-acetyltransferase (SSAT), which
are both involved in polyamine metabolism, suggesting that polyamines are involved in osteogenic differentiation of AT-MSCs.
Furthermore, treatment of AT-MSCs with the polyamine spermine-regulated gene expression of runx-2, a transcription factor involved in
early stages of osteogenic differentiation, and that of osteopontin, a bone matrix protein expressed in later stages of osteogenic differen-
tiation. Runx-2 gene expression was increased 4 and 14 days after a short 30 min. treatment with spermine, while osteopontin gene
expression was only increased 4 days after spermine treatment. Finally, alkaline phosphatase activity, which is intimately involved in the
formation of extracellular matrix of bone, was increased 4 weeks after the 30 min.-spermine treatment of AT-MSCs. In conclusion, this
study shows for the first time that the polyamine spermine regulates differentiation of AT-MSCs along the osteogenic lineage, which can
be used as a new method for differentiation of AT-MSCs along the osteogenic lineage. Therefore, polyamines may constitute a promising
tool for bone tissue engineering approaches using AT-MSCs, such as a one-step surgical procedure for spinal interbody fusion.
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harvesting and processing of AT-MSCs from adipose tissue,
osteogenic stimulation of the cells, by, for example, growth factors
for a short period of time (30 min.), seeding of stimulated cells on
a scaffold, and implantation of the tissue-engineered construct
between two vertebrae. The integrated steps can be accomplished
within one surgical procedure [6, 7]. 
For bone tissue engineering, it is important that stem cells
differentiate into osteoblast-like cells, and display a bone cell-
like response to mechanical loading [6]. Polyamines, which are
organic cations derived from amino acids, may be involved in
both processes. Polyamines have been associated with a variety
of biological processes such as proliferation, differentiation, and
apoptosis [8–10]. Furthermore, polyamines were suggested to
be involved in growth and development of a range of mammalian
tissues, and in re-modelling processes associated with tissue
repair [8–10]. In addition to normal growth and development,
polyamines have also been associated with tumour growth and
metastasis, and enhanced polyamine levels and high activity of
enzymes involved in polyamine biosynthesis were observed in
tumour cells [11]. Cellular polyamine levels are tightly regulated
by a complex network of factors that are involved in polyamine
biosynthesis and catabolism [12]. Biosynthesis includes the
conversion of the amino acid ornithine to the polyamine
putrescine, and subsequently to the polyamines spermidine and
spermine. Catabolism of polyamines is mediated via acetylation
of spermidine and spermine by the spermidine/spermine N (1)-
acetyltransferase (SSAT), which targets them for cellular excre-
tion, or results in their conversion into putrescine [12]. Gene
expression of SSAT is regulated by the polyamine-modulated
transcription factor-1 (PMF-1) [13, 14]. Polyamines are inti-
mately involved in their own biosynthesis and degradation, since
both SSAT and PMF-1 have polyamine-responsive elements in
their promotor [13, 14].
Several studies have implicated polyamines in bone and carti-
lage growth and development [15–17]. Polyamines were shown to
be abundantly present in the ossifying area as compared to the
resting region in epiphyseal cartilage from calf scapulas [15], and
alkaline phosphatase activity, which is a marker for bone cell dif-
ferentiation, was enhanced by polyamines [15]. This suggests that
polyamines may play a role in calcification of pre-osseous carti-
lage. Furthermore, the activity of enzymes involved in polyamine
metabolism and polyamine levels in rabbit costal chondrocytes
are regulated by parathyroid hormone (PTH), which is involved in
bone re-modelling [16]. Finally, polyamines have been demon-
strated to regulate cyclooxygenase-2 (COX-2) expression [17],
which is intimately involved in bone adaptation to mechanical
loading [18, 19]. Together, these studies implicate an important
role for polyamines in bone growth and development. Recent
studies in our laboratory have implicated polyamines in the
response of AT-MSCs to mechanical loading [20]. The polyamine
spermine was shown to inhibit nitric oxide production and COX-2
gene expression induced by mechanical loading as applied by pul-
sating fluid flow (PFF), suggesting that polyamines modulate the
response of human AT-MSCs to mechanical loading [20]. Whether
polyamines are involved in the differentiation of AT-MSCs along
the osteogenic lineage is currently unknown.
We first hypothesized that expression of the polyamine-related
genes SSAT and PMF-1 is regulated during 1,25(OH)2D3-stimulated
osteogenic differentiation of AT-MSCs. 1,25(OH)2D3 increased gene
expression of SSAT and PMF-1 by AT-MSCs, suggesting that
polyamine levels are modulated during osteogenic differentiation.
Therefore we further hypothesized that polyamines themselves may
stimulate osteogenic differentiation of AT-MSCs after a short treat-
ment period of only 30 min. We investigated whether the polyamine
spermine affects gene expression of runx-2, which is a transcription
factor critically involved in early stages of osteogenic differentiation,
and osteopontin, which is a bone matrix protein expressed during
later stages of osteogenic differentiation. We also studied whether
spermine affects alkaline phosphatase (ALP) activity, which is inti-
mately involved in bone extracellular matrix formation. 
This study may support the use of polyamines as a novel
approach for differentiation of AT-MSCs towards osteoblasts. This
new method may be used in tissue engineering approaches target-
ing skeletal defects, such as the one-step surgical procedure for
spinal interbody fusion.
Materials and methods
Isolation of AT-MSCs
AT-MSCs were isolated as described by Zuk et al. [2, 3] with minor modi-
fications. Briefly, goat adipose tissue was resected from the renal region of
4 adolescent female goats. The animal care and use committee of the Vrije
Universiteit Amsterdam approved the use of goats in these experiments.
The obtained tissue was washed with phosphate buffered saline (PBS) to
remove red blood cells, chopped into small pieces of about 50 mm3, and
the extracellular matrix was digested for 90 min. at 37°C with 0.05% col-
lagenase (type 1, Sigma, St Louis, MO, USA) in PBS. A single cell suspen-
sion was obtained by filtering the digested material through a 100 µm
mesh filter (Stokvis & Smith B.V., IJmuiden, The Netherlands) to remove
tissue debris. The AT-MSC-containing cell suspension was centrifuged at
600 g, and the pellet was re-suspended in culture medium, which was
composed of Dulbecco’s modified Eagle’s medium (D-MEM, Gibco,
Paisley, UK) supplemented with 500 µg/ml streptomycin sulphate (Sigma),
600 µg/ml penicillin (Sigma), 50 µg/ml gentamycin (Gibco), 2.5 µg/ml fun-
gizone (Gibco) and 10% foetal bovine serum (Hyclone, Logan, UT, USA).
The re-suspended cells were incubated for 15 min. at 37°C with 160 mM
NH4Cl (Merck, Darmstadt, Germany) to destroy remaining erythrocytes.
AT-MSCs were then washed three times with culture medium, and imme-
diately used for experiments. The polyamine spermine was added, and
cells were post-incubated as described below. 
Approximately 0.5–2% of the isolated cells do form colony-forming
units (CFUs) [4]. Furthermore, goat-AT-MSCs were characterized as
described by Knippenberg et al. [5]. Briefly, approximately 35% of freshly
isolated AT-MSCs was positive for the stem cell marker CD105/endoglin,
while 30% was positive for the stem cell marker CD166/ALCAM. In addi-
tion, cultured cells were shown to express the intermediate filament
vimentin, which is predominantly found in MSCs [5].
AT-MSC culture and stimulation
To induce osteogenic differentiation, goat-derived AT-ASCs (passage 2)
were seeded at 2 x 105 cells/well in 6-well plates (Corning Incorporated,
Corning, NY, USA), and osteogenic differentiation was induced by culturing
the cells in culture medium supplemented with 0.1 mg/ml ascorbic acid
(Merck), 10 mM -glycerophosphate (Sigma), and 10 nM 1,25(OH)2D3
(Sigma) for 7 or 14 days. Control cells were cultured in culture medium
without supplements. After 7 or 14 days, cells were harvested and lysed in
Trizol® reagent (Invitrogen, Carlsbad, CA, USA) for total RNA isolation.
Gene expression of runx-2, osteopontin, PMF-1 and SSAT was determined
by real time PCR. 
For stimulation of cells with spermine, freshly isolated AT-MSCs were
incubated for 30 min. in culture medium alone (control), or in culture
medium containing 0.1 mg/ml ascorbic acid (Merck) and 10 mM -glyc-
erophosphate (Sigma) with or without various concentrations (1, 3, 10 and
30 µM) of the polyamine spermine (Sigma). Thereafter, cells were seeded
in 6-well culture dishes (Corning Incorporated, Corning, NY, USA) at 18 x
104 cells per well, and cultured without spermine for 4–28 days in culture
medium alone, or in medium containing 0.1 mg/ml ascorbic acid (Merck)
and 10 mM -glycerophosphate (Sigma). Medium was refreshed twice a
week. After 4 and 14 days, mRNA was isolated, and gene expression of
SSAT, runx-2 and osteopontin was determined by real time PCR. After 2, 3
and 4 weeks, ALP activity was determined as described below. 
Real time PCR
Total RNA was extracted using Trizol® Reagent (Invitrogen) according to the
manufacturer’s instructions. To increase RNA yield, 5 µg glycogen (Roche
Diagnostics, Mannheim, Germany) was added to RNA in isopropanol prior to
centrifugation. Total RNA (500–750 ng) was reverse transcribed using 250
U/ml Transcriptor Reverse Transcriptase (Roche Diagnostics, Mannheim,
Germany), 0.08 A260 units random primers (Roche Diagnostics, Mannheim,
Germany), and 1 mM of each dNTP (Invitrogen) in Transcriptor reverse tran-
scriptase (RT) reaction buffer for 30 min. at 55˚C followed by 5 min. inacti-
vation of reverse transcriptase at 85C. The cDNA was diluted (5–10x) and 
2 µl of cDNA was used per reaction for real-time PCR using a SYBRGreen
reaction kit for 18S (3 mM MgCl2) or Fast start plus SYBRGreen kit (both
from Roche Diagnostics) for SSAT, runx-2 and osteopontin in a LightCycler
(Roche Diagnostics). PCR conditions were as follows. For 18S: 1 min. pre-
incubation at 95°C, followed by 30 cycles of amplification at 95°C for 5 sec.,
56°C for 10 sec., 72°C for 15 sec., and 82°C for 5 sec., followed by melting
curve analysis; for SSAT: 10 min. pre-incubation at 95°C, followed by 35
cycles of amplification at 95°C for 5 sec., 57°C for 5 sec., 72°C for 15 sec.,
and 82°C for 5 sec. followed by melting curve analysis; for PMF-1: 10 min
pre-incubation at 95°C, followed by 35 cycles of amplification at 95°C for 5
sec., 57°C for 5 sec., 72°C for 15 sec., and 82°C for 5 sec. followed by melt-
ing curve analysis; for runx-2: 10 min pre-incubation at 95°C, followed by 35
cycles of amplification at 95°C for 2 sec., 55°C for 8 sec., 72°C for 10 sec.,
and 82°C for 5 sec., followed by melting curve analysis; for osteopontin: 10
min. pre-incubation at 95°C, followed by 35 cycles of amplification at 95°C
for 2 sec., 57°C for 8 sec., 72°C for 10 sec., and 82°C for 5 sec., followed by
melting curve analysis. 
With the Light Cycler software (version 1.2), the crossing points were
assessed and plotted versus the serial dilution of known concentrations of
the standards derived from each gene. PCR efficiency (E) was obtained by
using the formula E = 10–1/slope. Data were used only if the PCR efficiency
calculated was between 1.85 and 2.0. 
To avoid contamination with genomic DNA, intron-spanning primers
(except for 18S) were designed (Table 1) using Clone manager suite soft-
ware program version 6 (Scientific & Educational Software, Care, NC, USA),
and used at a concentration of 1 µM. Data analysis was performed using the
Light Cycler software (version 2). After normalization for 18S housekeeping
gene expression, relative target gene expression was determined.
ALP activity
Goat-derived AT-MSCs were seeded at a density of 104 cells/cm2, either or
not stimulated with spermine for 30 min., and cultured for 1, 3 or 4 weeks.
The cells were washed with PBS, and fixed in 4% paraformaldehyde
(Sigma) for 15 min. at 4C. The cells were washed again with PBS, and
incubated with 0.1 M Tris buffer at pH 9,5 for 10 min. at room temperature.
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Target gene Oligonucleotide sequence
Product size (bp),  and acc.nr.
GenBank
Annealing 
temperature (°C)
18s -FW 5 -gtaacccgttgaaccccatt- 3 151, gi|76363890| 56
18s -REV 5 -ccatccaatcggtagtagcg- 3
Runx2 -FW 5 -atgcttcattcgcctcac - 3 156, gi|76363891| 56
Runx2 -REV 5 -actgcttgcagccttaaat - 3
OPN -FW 5 -ttccaagtaagtccaacgaaag-3 151, gi|76363893| 56
OPN -REV 5 -gtgaccagttcatcagattcat- 3
SSAT-FW 5 -gacatactgcggctgatcaa - 3 225, gi|76363895| 58
SSAT -REV 5-ccaatccacgggtcataggtaa- 3
PMF-1 -FW 5 - tcttcagaagctggtcgc - 3 219, gi|76363897| 56
PMF-1-REV 5- cggactttgccttcttccac - 3
Table 1 Primers used for real time PCR
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Staining of the cells was performed using 0.1 M Tris buffer containing 
0.1 M NaCl (Sigma), 0.05 M MgCl2 (Sigma) and 50x diluted with 4-Nitro
blue tetrazolium chloride/ 5-Bromo-4-chloro-3-indolyl-phosphate, dis-
odium salt (NBT/BCIP; Roche Diagnostics GmbH, Mannheim, Germany)
for 30 min. Thereafter, the cells were washed with water and incubated for
5 min. in 100% methanol (Sigma) to remove non-specific background
staining, and cells staining positive for ALP activity were counted.
Statistical analysis
Data on gene expression were obtained from six separate experiments
using six different goats, and data on ALP activity were obtained from four
separate experiments using four different goats. When indicated, real-time
PCR data were log-transformed in order to obtain normally distributed
data. Treatment-over-control (T/C) values were not log-transformed. Data
are presented as mean ± SEM, and statistical analysis was performed
using the Student's t test.
Results
To study whether expression of genes involved in polyamine
metabolism is modulated during osteogenic stimulation in AT-
MSCs, goat-derived AT-MSCs were stimulated for 7 or 14 days in
osteogenic medium containing 10 nM 1,25(OH)2D3, and gene
expression of the polyamine-related genes SSAT and PMF-1 was
determined. 1,25(OH)2D3 stimulated osteogenic differentiation of
AT-MSCs as shown by increased gene expression of both runx-2
(Fig. 1A), which is a transcription factor involved in early stages of
osteogenic differentiation, and osteopontin (Fig. 1B), which is a
bone matrix molecule expressed during later stages of osteogenic
differentiation, after 14 days. Gene expression of both SSAT (Fig.
1C) and PMF-1 (Fig. 1D) was increased after 7 days stimulation in
osteogenic medium, suggesting involvement of polyamines in
osteogenic differentiation of AT-MSCs.
To study whether polyamines may be used in the one-step sur-
gical procedure for spinal interbody fusion, we investigated
whether stimulation of AT-MSCs with the polyamine spermine for
a short period of time (30 min.) stimulated expression of genes
involved in osteogenic differentiation. Therefore, we first exam-
ined whether goat-derived AT-MSCs are responsive to polyamines,
by measuring the effect of the polyamine spermine on gene
expression of SSAT, which regulates polyamine catabolism. Cells
were treated with spermine for 30 min., and 4 days after treat-
ment, gene expression of SSAT was determined by real time PCR.
Treatment of AT-MSCs with spermine at concentrations of 
Fig. 1 Effect of 1,25(OH)2D3 on runx-2 
(A), osteopontin (B), SSAT (C) and
polyamine-modulated transcription factor-
1 (PMF-1) (D) gene expression in goat-
derived adipose tissue-derived mesenchy-
mal stem cells AT-MSCs. Cells were stim-
ulated for 7 or 14 days in medium contain-
ing 10 nM 1,25(OH)2D3, and gene expres-
sion was determined by real time PCR.
Data are log-transformed, normalized to
18S gene expression, and presented as
mean ± SEM of treatment-over-control
(T/C) ratios; dashed line, T/C = 1 (no effect).
SSAT, spermidine/ spermine N (1)-acetyl-
transferase; PMF-1, polyamine-modulated
transcription factor-1; OPN, osteopontin. 
* Significant effect of spermine, P < 0.05.
3–30 µM significantly increased SSAT gene expression, with a
maximum increase of 2.6-fold at 3 µM spermine, suggesting that
AT-MSCs are responsive to spermine (Fig. 2). Fourteen days
after a 30 min. treatment with spermine, SSAT gene expression
in cells treated with spermine was similar to that in control cells
(data not shown).
Four days after treatment of AT-MSCs with 3–30 µM spermine,
runx-2 gene expression was significantly increased, reaching a 2.4-
fold increase at 3 µM spermine (Fig. 3A). In addition, 14 days after
treatment with 10-µM spermine, runx-2 gene expression was
increased by 3.8-fold (Fig. 3B). Furthermore, four days after treat-
ment of AT-MSCs with 30-µM spermine, osteopontin gene expres-
sion was significantly increased by 9.8-fold (Fig. 4A), while no 
significant effect of spermine on osteopontin gene expression 
was observed 14 days after treatment (Fig. 4B).
To further evaluate the effect of spermine on differentiation
of AT-MSCs along the osteogenic lineage, the effect of spermine
treatment on ALP activity was studied. Cells were treated for 
30 min. with different concentrations spermine (1–30 µM), and
after 1, 3 and 4 weeks ALP activity was visualized using
NBT/BCIP. The number of AT-MSCs showing positive staining
for ALP activity was significantly increased by 1.4-fold, 4 weeks
after treatment with 3 µM spermine (Fig. 5). The total number of
cells was not changed by spermine (data not shown).
Discussion
In the present study, we present a new method for differentiation
of AT-MSCs along the osteogenic lineage. We demonstrate that
polyamines are involved in 1,25(OH)2D3-induced osteogenic dif-
ferentiation of AT-MSCs. Furthermore, treatment of AT-MSCs with
the polyamine spermine for 30 min. was shown to regulate gene
expression of runx-2 and osteopontin, which are involved in early
and later stages of osteogenic differentiation, respectively. In addi-
tion, spermine treatment was shown to increase the number of
cells staining positive for ALP activity, which is important for the
formation of extracellular bone matrix. Our findings demonstrate
that stimulation of AT-MSCs with the polyamine spermine can 
be used as a new procedure for differentiation of AT-MSCs along
the osteogenic lineage.
For bone tissue engineering it is important that stem cells
display a bone cell-like response to mechanical loading, and
differentiate along the osteogenic lineage. Earlier studies in our
laboratory have shown that polyamines inhibit PFF-induced NO
production and COX-2 gene expression [20], suggesting that
polyamines regulate the response of AT-MSCs to mechanical
loading. In the present study, we investigated whether
polyamines are involved in 1,25(OH)2D3-induced osteogenic
differentiation of AT-MSCs, and whether they regulate differen-
tiation of AT-MSCs towards the osteogenic lineage. We found
that spermine increases gene expression of both runx-2 and
osteopontin, and the number of cells exhibiting activated ALP,
suggesting that spermine regulates osteogenic differentiation of
AT-MSCs. Interestingly, treatment of AT-MSCs with spermine
for only 30 min. resulted in changes in ALP activity for up to 4
weeks after treatment, indicating that spermine may be an inter-
esting tool for treatment of disc degeneration by spinal fusion
using the one-step procedure, which requires osteogenic
stimulation of AT-MSCs for a short period of time to direct
differentiation of AT-MSCs towards the osteogenic lineage.
Intracellular polyamine levels are tightly regulated by a group
of interrelated factors that control both biosynthesis and catabo-
lism via different enzymatic steps [12]. Disregulation of cellular
polyamine homeostasis has been associated with tumour forma-
tion and metastasis [11]. Continuous high levels of polyamines
and enzymes involved in polyamine metabolism, have been
demonstrated in different forms of cancer, and enzymes involved
in polyamine metabolism are currently evaluated as targets for the
development of anti-cancer drugs [23]. We show that 30 min.
treatment of AT-MSCs with the polyamine spermine increases
gene expression of SSAT, which targets polyamines for degrada-
tion, suggesting that polyamine homeostasis will be restored
shortly after polyamine treatment. This is supported by the obser-
vation that 14 days after spermine treatment, SSAT gene expres-
sion has returned to basal levels (data not shown). Restoring
polyamine homeostasis may be important, since continued stim-
ulation of cells with polyamines may result in pathological condi-
tions, such as tumour formation and metastases. 
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Fig. 2 Effect of spermine on SSAT gene expression in goat-derived AT-
MSCs. Cells were treated for 30 min. with or without various concentra-
tions of spermine, and 4 days after treatment, SSAT gene expression
was determined by real time PCR. Data are normalized to 18S gene
expression, and presented as mean ± SEM of treatment-over-control
(T/C) ratios; dashed line, T/C = 1 (no effect). SSAT, spermidine/spermine
N (1)-acetyltransferase. * Significant effect of spermine, P<0.05.
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The polyamines putrescine, spermidine and spermine affect
various cellular processes [8–10]. While polyamines are derived
from the same precursor, the various polyamines have been
demonstrated to activate different intracellular signalling path-
ways [24]. Both polyamines putrescine and spermidine have
been shown to stimulate tyrosine phosphorylation by tyrosine
kinases [24]. However, while putrescine increases the expres-
sion of the transcription factors c-fos and c-jun, spermidine acti-
vates mitogen-activated protein kinases (MAPKs) and c-myc
[24]. In contrast to putrescine and spermidine, the signal trans-
duction pathways activated by spermine are still poorly
described [24]. Activation of different intracellular signalling
pathways by the various polyamines indicates that they display
different effects on cellular activities. In the present study, we
Fig. 3 Effect of spermine on runx-2 gene expression in goat-derived AT-MSCs. Cells were treated for 30 min. with or without various concentrations
of spermine, and 4 days (A) and 14 (B) days after treatment, runx-2 gene expression was determined by real time PCR. Data are normalized to 18S
gene expression, and presented as mean ± SEM of treatment-over-control (T/C) ratios; dashed line, T/C = 1 (no effect). * Significant effect of 
spermine, P<0.05.
Fig. 4 Effect of spermine on osteopontin gene expression in goat-derived AT-MSCs. Cells were treated for 30 min. with or without various concentra-
tions of spermine, and 4 days (A) and 14 (B) days after treatment, osteopontin gene expression was determined by real time PCR. Data are 
normalized to 18S gene expression, and presented as mean ± SEM of treatment-over-control (T/C) ratios; dashed line, T/C = 1 (no effect). OPN, 
osteopontin. * Significant effect of spermine, P<0.05.
show that the polyamine spermine affects differentiation of AT-
MSCs. Since putrescine and spermidine may display different
effects on cellular activities as compared to spermine, the effects
of these polyamines on the differentiation of AT-MSCs needs fur-
ther study. 
In conclusion, this study presents a new way for differentia-
tion of AT-MSCs along the osteogenic lineage by stimulation of
AT-MSCs with the polyamine spermine. This new method may
be used in tissue engineering approaches targeting skeletal
defects, such as the one-step surgical procedure for spinal
interbody fusion.
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